Therapy of chronic myelogenous leukemia: chemotherapy and interferons.

Suppr

超能文献

作者信息

Talpaz M, Kantarjian H M, Kurzrock R, Gutterman J

机构信息

Department of Clinical Immunology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.

出版信息

Semin Hematol. 1988 Jan;25(1):62-73.

PMID:2450402

Abstract

摘要

相似文献

Therapy of chronic myelogenous leukemia: chemotherapy and interferons.

Semin Hematol. 1988 Jan;25(1):62-73.

[Treatment of chronic myeloid leukemia].[慢性髓性白血病的治疗]

Nouv Rev Fr Hematol (1978). 1993 Jun;35(3):151-4.

Chronic myelogenous leukemia: is aggressive treatment indicated?慢性粒细胞白血病：是否需要积极治疗？

J Clin Oncol. 1985 Feb;3(2):135-9. doi: 10.1200/JCO.1985.3.2.135.

[Interferon in the treatment of Philadelphia-positive chronic myeloid leukemia].

Haematologica. 1990 Jul-Aug;75 Suppl 4:33-40.

[Chronic myeloid leukemia: a decade of progress].[慢性髓性白血病：十年进展]

Med Clin (Barc). 1990 Jan 13;94(1):27-35.

[Interferon in chronic myeloid leukemia].[干扰素在慢性粒细胞白血病中的应用]

Dtsch Med Wochenschr. 1987 Dec 4;112(49):1919.

[Chronic myeloid leukemia. Diagnosis, evolution and prognosis, treatment].[慢性髓性白血病。诊断、进展与预后、治疗]

Rev Prat. 1990 Sep 11;40(20):1879-85.

Interferons as anticancer agents.干扰素作为抗癌剂。

Am Fam Physician. 1984 Jun;29(6):246-8.

New developments in the treatment of acute myeloid leukemia: focus on topotecan.急性髓系白血病治疗的新进展：聚焦于拓扑替康

Semin Hematol. 1999 Oct;36(4 Suppl 8):16-25.

Myeloid sarcoma presenting as an isolated nodule in a patient with acute myelogenous leukemia.髓系肉瘤在一名急性髓系白血病患者中表现为孤立性结节。

J Drugs Dermatol. 2007 Apr;6(4):447-50.

引用本文的文献

Immunologic Profile of Patients Suffering from Herpes Simplex Virus (HSV) -Associated Oral Lesions Treated with Natural Human Interferon Alpha (Egiferon).接受天然人干扰素α（爱夫吉夫）治疗的单纯疱疹病毒（HSV）相关口腔病变患者的免疫特征

Pathol Oncol Res. 1997;3(1):44-46. doi: 10.1007/BF02893352.

A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia.

Blut. 1989 Jun;58(6):275-8. doi: 10.1007/BF00320165.

Clinical evaluation of treatment with interferon.干扰素治疗的临床评估

Med Oncol Tumor Pharmacother. 1989;6(1):87-91. doi: 10.1007/BF02985228.

Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-alpha-treated chronic myelogenous leukaemia patients.来自干扰素-α治疗的慢性粒细胞白血病患者的淋巴因子激活效应细胞对自体靶细胞的裂解敏感性。

Cancer Immunol Immunother. 1990;32(3):167-72. doi: 10.1007/BF01771452.

Characterization of three monoclonal antibodies that recognize the interferon alpha 2 receptor.三种识别干扰素α2受体的单克隆抗体的特性鉴定

Proc Natl Acad Sci U S A. 1990 Sep;87(18):7230-4. doi: 10.1073/pnas.87.18.7230.

In vivo induction of HLA molecules in patients with myeloproliferative syndrome during IFN alpha treatment.α干扰素治疗期间骨髓增殖综合征患者体内HLA分子的诱导

Ann Hematol. 1991 Nov;63(5):259-63. doi: 10.1007/BF01698375.

The roles of age and sex in the prognosis of chronic leukaemias. A study of 373 cases.年龄和性别在慢性白血病预后中的作用。373例病例研究。

Br J Cancer. 1991 Aug;64(2):345-8. doi: 10.1038/bjc.1991.303.

Confirmation and improvement of Sokal's prognostic classification of Ph+ chronic myeloid leukemia: the value of early evaluation of the course of the disease. The Italian Cooperative Study Group on Chronic Myeloid Leukemia.

Ann Hematol. 1991 Dec;63(6):307-14. doi: 10.1007/BF01709652.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验